These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2530930)

  • 1. [Antiandrogens. Mechanisms and paradoxical effects].
    Mowszowicz I
    Ann Endocrinol (Paris); 1989; 50(3):189-99. PubMed ID: 2530930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
    Furr BJ; Tucker H
    Urology; 1996 Jan; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Steroidal and nonsteroidal antiandrogens: chemical structures, mechanisms of action and clinical applications].
    Akakura K; Furuya Y; Ito H
    Nihon Rinsho; 1998 Aug; 56(8):2124-8. PubMed ID: 9750520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer.
    Mahler C; Verhelst J; Denis L
    Clin Pharmacokinet; 1998 May; 34(5):405-17. PubMed ID: 9592622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection.
    Nguyen TV; Yao M; Pike CJ
    Endocrinology; 2007 Jun; 148(6):2936-43. PubMed ID: 17347309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICI 176,334: a novel non-steroidal, peripherally-selective antiandrogen.
    Furr BJ
    Prog Clin Biol Res; 1988; 260():13-26. PubMed ID: 2966405
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of antiandrogens and value of combining androgen suppression with antiandrogen therapy.
    Gaillard-Moguilewsky M
    Urology; 1991; 37(2 Suppl):5-12. PubMed ID: 1992602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-specific action of antiandrogens on androgen induced changes in hepatic microsomal 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase activity in the rat.
    Lax ER; Schriefers H
    Acta Endocrinol (Copenh); 1981 Oct; 98(2):261-6. PubMed ID: 6457494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two non-steroidal antiandrogens on testicular function in prepubertal rats.
    Rulli SB; Gonzalez-Calvar SI; Campo S; Calandra RS
    J Androl; 1995; 16(3):225-32. PubMed ID: 7559155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei.
    Karvonen U; Jänne OA; Palvimo JJ
    FEBS Lett; 2002 Jul; 523(1-3):43-7. PubMed ID: 12123801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural and quantitative immunohistochemical changes induced by nonsteroid antiandrogens on pituitary gonadotroph population of prepubertal male rats.
    Cónsole GM; Jurado SB; Rulli SB; Calandra RS; Gómez Dumm CL
    Cells Tissues Organs; 2001; 169(1):64-72. PubMed ID: 11340263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy.
    Migliari R; Muscas G; Murru M; Verdacchi T; De Benedetto G; De Angelis M
    Arch Ital Urol Androl; 1999 Dec; 71(5):293-302. PubMed ID: 10673793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
    Whitaker HC; Hanrahan S; Totty N; Gamble SC; Waxman J; Cato AC; Hurst HC; Bevan CL
    Clin Cancer Res; 2004 Nov; 10(21):7392-401. PubMed ID: 15534116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cyproterone acetate in prostate cancer.
    Goldenberg SL; Bruchovsky N
    Urol Clin North Am; 1991 Feb; 18(1):111-22. PubMed ID: 1825143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of androgens and antiandrogens on the quantitative immunohistochemistry of gonadotrope cells in prepubertal male rats.
    Cónsole GG; Rulli SB; Riccillo FL; Calandra RS; Gómez Dumm CL
    Neuroendocrinology; 1999 Oct; 70(4):261-7. PubMed ID: 10529621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen metabolism in hirsute patients treated with cyproterone acetate.
    Mowszowicz I; Wright F; Vincens M; Rigaud C; Nahoul K; Mavier P; Guillemant S; Kuttenn F; Mauvais-Jarvis P
    J Steroid Biochem; 1984 Mar; 20(3):757-61. PubMed ID: 6231428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino terminus of the human AR is target for corepressor action and antihormone agonism.
    Dotzlaw H; Moehren U; Mink S; Cato AC; Iñiguez Lluhí JA; Baniahmad A
    Mol Endocrinol; 2002 Apr; 16(4):661-73. PubMed ID: 11923464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-androgens in gynaecological practice.
    Reed MJ; Franks S
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):581-95. PubMed ID: 2976627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiandrogens: clinical applications.
    Sciarra F; Toscano V; Concolino G; Di Silverio F
    J Steroid Biochem Mol Biol; 1990 Nov; 37(3):349-62. PubMed ID: 2147859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells.
    Miyamoto H; Yeh S; Wilding G; Chang C
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7379-84. PubMed ID: 9636157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.